Stem cell collection in unmanipulated HLA-haploidentical/mismatched related transplantation with combined granulocyte-colony stimulating factor-mobilised blood and bone marrow for patients with haematologic malignancies: the impact of donor characteristics and procedural settings.
Unmanipulated haploidentical/mismatched related transplantation with combined granulocyte-colony stimulating factor-mobilised peripheral blood stem cells (G-PBSCs) and granulocyte-colony stimulating factor-mobilised bone marrow (G-BM) has been developed as an alternative transplantation strategy for patients with haematologic malignancies. However, little information is available about the factors predicting the outcome of peripheral blood stem cell (PBSC) collection and bone marrow (BM) harvest in this transplantation. The effects of donor characteristics and procedure factors on CD34(+) cell yield were investigated. A total of 104 related healthy donors received granulocyte-colony stimulating factor (G-CSF) followed by PBSC collection and BM harvest. Male donors had significantly higher yields compared with female donors. In multiple regression analysis for peripheral blood collection, age and flow rate were negatively correlated with cell yield, whereas body mass index, pre-aphaeresis white blood cell (WBC) and circulating immature cell (CIC) counts were positively correlated with cell yields. For BM harvest, age was negatively correlated with cell yields, whereas pre-BM collection CIC counts were positively correlated with cell yield. All donors achieved the final product of >or=6 x10(6) kg(-1) recipient body weight. This transplantation strategy has been shown to be a feasible approach with acceptable outcomes in stem cell collection for patients who received HLA-haploidentical/mismatched transplantation with combined G-PBSCs and G-BM. In donors with multiple high-risk characteristics for poor aphaeresis CD34(+) cell yield, BM was an alternative source.
Department of Hematology, Xinqiao Hospital, The Third Military Medical University, Chongqing, People's Republic of China.
C
C
Zhang
X-H
XH
Chen
X
X
Zhang
L
L
Gao
L
L
Gao
P-Y
PY
Kong
X-G
XG
Peng
A-H
AH
Sun
Y
Y
Gong
D-F
DF
Zeng
Q-Y
QY
Wang
D000293:Adolescent; D000328:Adult; D001772:Blood Cell Count; D001782:Blood Donors / Q000706:statistics & numerical data; D016026:Bone Marrow Transplantation / Q000379:methods*; D002648:Child; D005190:Family; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage / Q000494:pharmacology*; D006680:HLA Antigens / Q000235:genetics*; D019337:Hematologic Neoplasms / Q000235:genetics / Q000628:therapy*; D019650:Hematopoietic Stem Cell Mobilization; D006648:Histocompatibility; D006801:Humans; D007937:Leukapheresis / Q000379:methods; D019520:Living Donors / Q000706:statistics & numerical data; D008297:Male; D008875:Middle Aged; D036102:Peripheral Blood Stem Cell Transplantation / Q000379:methods*; D055815:Young Adult
D006680:HLA Antigens; D016179:Granulocyte Colony-Stimulating Factor